Delivery Order SPE2DE22D0008-SPE2D624F2V16

Award Date 3/20/24
Potential Completion Date 5/22/24
Potential Value $1.9K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Chicago, IL 60607, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency's Medical Supply Chain division to Alba Bioscience, Inc., a foreign-owned, for-profit organization that specializes in providing in vitro diagnostics, blood bank reagents, antibody screening tests, and quality control materials to various U.S. government agencies. The contract, valued at $10,683.00, is for the delivery of ALBACYTE antibody identification panels and is a firm fixed-price agreement with a completion date...
This federal contract award to Alba Bioscience, Inc., a foreign-owned for-profit organization, is for the supply of specialized in vitro diagnostics, blood bank reagents, antibody screening tests, and quality control materials. The contract, valued at $6,750.00, was awarded by the Defense Logistics Agency (DLA) Medical Supply Chain division to support defense medical operations. The contract is a delivery order under a larger Indefinite Delivery Vehicle (IDV), likely a Blanket Purchase Agreement...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Alba Bioscience, Inc., a foreign-owned for-profit organization, for the provision of ALBACLONE ANTI-A medical supplies. The contract has a ceiling value of $1,123.00 and a period of performance through April 4, 2024. It is a firm fixed price contract, and there was no set-aside designation used. Alba Bioscience, Inc. is a leading provider of specialized in vitro diagnostics and blood bank reagents, and this...
This is a federal contract award to Alba Bioscience, Inc., a for-profit medical supply company, by the Defense Logistics Agency (DLA) Medical Supply Chain. The contract is for the delivery of ALBACYTE antibody screening tests, with a ceiling value of $2,520.00 and a period of performance through April 15, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. Alba Bioscience, Inc. is a subsidiary of Quotient Biodiagnostics, Inc. and is a leading supplier of...
This federal contract award, valued at $2,378.29, was issued by the Defense Logistics Agency (DLA) Medical Supply Chain to Alba Bioscience, Inc., a foreign-owned, for-profit organization that specializes in providing in vitro diagnostics, blood bank reagents, antibody screening tests, and quality control materials to various U.S. government agencies. The contract is a delivery order for the ALBACYTE Antibody Screen (3-cell), a critical blood banking product used to support medical operations...
This contract, awarded by the Defense Logistics Agency (DLA), is a Delivery Order for $14,457.00 with Alba Bioscience, Inc., a foreign-owned, for-profit organization that specializes in providing in vitro diagnostics, blood bank reagents, antibody screening tests, and quality control materials to various U.S. government agencies. The contract is for the delivery of ALBACLONE Anti-A products and has a completion date of September 5, 2024. This contract is not designated as a set-aside. Alba...
This federal contract award is for the delivery of ALBACYTE antibody screening tests (3-cell) to the Defense Logistics Agency (DLA). The $1,281.00 firm-fixed-price contract was awarded to Alba Bioscience, Inc., a foreign-owned, for-profit organization that specializes in in vitro diagnostics, blood bank reagents, and quality control materials. The award is not associated with a set-aside program and serves as a delivery order under the company's existing federal contract vehicles, including a...
This is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA) Medical Supply Chain to Alba Bioscience, Inc., a for-profit organization that specializes in providing in vitro diagnostics, blood bank reagents, antibody screening tests, and quality control materials to federal agencies. The $7,280.00 contract is for the delivery of ALBACYTE IGG Sensitized Cells II products to support diagnostic testing, blood typing, and transfusion services for federal healthcare...
This federal contract award, valued at $1,239.00, was made to Alba Bioscience, Inc., a foreign-owned, for-profit organization that specializes in providing in vitro diagnostics, blood bank reagents, antibody screening tests, and quality control materials. The contract, awarded by the Defense Logistics Agency's Medical Supply Chain division, is for the delivery of ALBACYTE antibody screening cells, a critical product used in blood banking operations across various government agencies, including...
This federal contract award, valued at $7,590.00, was issued by the Defense Logistics Agency (DLA) to Alba Bioscience, Inc., a foreign-owned, for-profit organization that specializes in providing in vitro diagnostics, blood bank reagents, and other specialized biomedical products to various federal agencies. The contract is for the delivery of ALBACYTE Antibody ID Panels, which are essential blood banking supplies used to support the DLA's medical operations. Alba Bioscience holds multiple...
  • SPE2DE22D0008
    Indefinite Delivery Contract
  • SPE2DE22D0008-SPE2D624F2V16
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Alba Bioscience, Inc., a foreign-owned for-profit organization registered in SAM.gov. The contract is for the supply of Albacyte Antibody Screen (3-Cell) medical testing kits, with a ceiling value of $1,906.00 and a period of performance through May 22, 2024. The contract has no set-aside designation. Alba Bioscience, Inc. is a subsidiary of Quotient Biodiagnostics, Inc., a leading provider of specialized in vitro diagnostics and blood bank reagents. This contract supports the agency's medical supply chain operations, facilitating the procurement of critical diagnostic testing supplies for blood banking and transfusion services across Department of Veterans Affairs (VA) medical facilities.

Generated 6/19/24, 9:21 AM